News

Overview of all reimbursed indications for the use of PD-(L)1 inhibitors in oncology

The use of immune checkpoint inhibitors in transplant patients

Immune checkpoint inhibitors might be used for organ transplant patients under special very controlled circumstances. Malignancy is a significant adverse …

New medical need programma available for pembrolizumab + chemo for 1st line head & neck tumors.

A platform has been made available in order to process the requests: https://msd-keytruda-hnscc-mnp.atramed.solutions On this website you can register a …

SAVE THE DATE: 22nd BSMO Annual Meeting 2020

BSMO Annual Meeting 2020 Scientific Programme – Friday 14 & Saturday 15 February 2020 We wish to invite you to …

Influenza vaccination and immune therapy

Influenza vaccination remains indicated in cancer patients, even under therapy with immune checkpoint inhibitors, see attached publication. Download statement

Candidates for BSMO Board membership

Dear colleague, Dear member, In 2019 a new board of the BSMO will have to be installed. Please click on the …

Announcement ImmunoManager

Go to the ImmunoManager website.

BSMO Sponsored trials

Precision medicine seeks to identify the best treat¬ment for each individual based on the pa¬tient’s unique characteristics. This approach could …

The role of the Medical Oncologist

The current and future role of the medical oncologist in the professional care for cancer patients: a position paper by the European …